Business
BioSpectrum Asia
AI and Prevention Drive Singapore's Healthcare Strategy in Budget 2026
On February 12, the Singapore government presented its 2026 National Budget, positioning it as a first step toward securing the country's future in a changing global environment.
4 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Avantor inks strategic collaboration with Parafilm to serve Indian lab consumables market
Avantor, Inc., a leading life science tools company and global provider of missioncritical products and services to the life sciences and advanced technology industries, has announced that Avantor India has been appointed the exclusive distributor of Amcor Parafilm M sealing wrap products in India.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Otsuka Pharma buys Transcend Therapeutics for $1.2 B
Japan-based Otsuka Pharmaceutical and US-based startup Transcend Therapeutics have entered into an agreement, under which Otsuka, through its wholly owned subsidiary Otsuka America, Inc., will fully acquire Transcend.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Moderna names Dr Carolyn Tucek-Szabo as General Manager for Australia and NZ
American biotech firm Moderna has announced the appointment of Dr Carolyn Tucek-Szabo as General Manager for Australia and New Zealand.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Merck India and MAHE launch Catalyst Programme to encourage talent in R&D
Merck, a leading science and technology company, has signed a Memorandum of Understanding (MoU) with Manipal Academy of Higher Education (MAHE), an Institution of Eminence Deemed to be University, Karnataka (India) to strengthen collaboration between academia and industry and help develop future-ready talent for the healthcare sector. Merck Healthcare R&D India has also launched its flagship programme- Catalyst at MAHE.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Nitin Wadhwa takes charge as General Manager, India at Sebia
French medtech firm Sebia has announced the appointment of Nitin Wadhwa as General Manager for India.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
India sets up National Dental Commission
In a significant reform aimed at improving the quality of dental education & bringing it at par with global standards, the Government of India has replaced the Dental Council of India (DCI) with the National Dental Commission (NDC) and three autonomous boards.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Celltrion announces KRW 1.2 T expansion of new DS production facilities in Songdo
South Korea-based Celltrion plans to secure additional manufacturing capacity through a large-scale expansion investment exceeding KRW 1 trillion at its Songdo headquarters to respond to rapidly increasing global demand for its biologics portfolio and further strengthen its global manufacturing competitiveness.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
FedEx collaborates with Korea Medical Devices Industry Association
Federal Express Corporation (FedEx), one of the world's largest express transportation companies, has announced a collaboration with the Korea Medical Devices Industry Association (KMDIA) to support Korean medical device manufacturers and exporters as they expand their global presence.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Lotus Pharmaceutical buys Sandoz AG's Philippines business
Taiwan-based Lotus Pharmaceutical has entered into an agreement to acquire Sandoz AG's Philippines business. Subject to closing conditions, the acquisition is expected to be completed in Q2 2026.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Kazia Therapeutics appoints Dr Sudha Rao as CSO
Australia-based Kazia Therapeutics, a clinical-stage oncology company developing differentiated therapies for cancers with high unmet need, has announced the appointment of Dr Sudha Rao as Chief Scientific Officer (CSO).
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Telix Pharma inks radiopharma collaboration worth $535 M with Regeneron
Australia-based Telix Pharmaceuticals and US-based Regeneron Pharmaceuticals, Inc have announced a collaboration to jointly develop and commercialise next generation radiopharmaceutical therapies.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
AI Tools Life Sciences Companies Are Using
Artificial Intelligence (AI) has steadily permeated every aspect of drug discovery and the life sciences industry. From discovering new molecules and accelerating clinical research to supporting Contract Development and Manufacturing Organisation (CDMOS) and improving dayto-day operations, AI is transforming how work gets done across the value chain. Let's explore some of the AI tools being leveraged by the life sciences companies.
5 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
China and ILO sign agreement on Occupational Safety and Health
The International Labour Organization (ILO) and the State Administration for Market Regulation of the People's Republic of China have signed a Memorandum of Understanding (MoU) to strengthen cooperation in special equipment safety and occupational safety and health (OSH).
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Kazakhstan achieves major public health milestone in Central Asia
Kazakhstan has achieved a major public health milestone, becoming the first country in Central Asia to reach Maturity Level 3 (ML3) for the regulation of medicines and imported vaccines under the World Health Organization's (WHO) global classification of national regulatory authorities.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
APAC Healthcare Pulses with Digital Innovation
Gone are the days when healthcare simply meant pills and potions. Today, every step of the journey is getting digitised.
10+ min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Diagens Biotechnology raises $101 M in Hong Kong IPO
Hangzhou Diagens Biotechnology has announced commencement of trading on the Main Board of The Stock Exchange of Hong Kong on March 31.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
INDIAN PHARMA'S ADAPTABILITY & STRESS TEST
India's pharmaceutical exports crossed $28 billion by February 2026, registering a modest growth of 5 per cent over the same period last year.
2 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Korea and Mongolia renew longstanding healthcare partnership
South Korea's Ministry of Health and Welfare recently held a bilateral meeting with Mongolia's Minister of Health, Jigjidsuren Chinburen, during his visit to Korea to attend Medical Korea 2026. Following the meeting, the two countries signed three agreements to strengthen cooperation in the referral of Mongolian governmentfunded patients and the training of healthcare professionals.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Mabwell establishes commercialisation agreement for Denosumab Biosimilars in Malaysia
Mabwell, a China-based innovation-driven biopharmaceutical company with a fully integrated industry chain, has established a licensing and commercialisation agreement with a strategic business partner in Malaysia for its Denosumab biosimilar products MAILISHU (a biosimilar of Prolia) and MAIWEIJIAN (a biosimilar of Xgeva).
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Senhwa Biosciences secures funding upto NT$500 M to accelerate AI-driven drug development
Senhwa Biosciences, Inc., a Taiwan-based clinical-stage biopharmaceutical company, has announced the signing of a Memorandum of Understanding (MoU) with GEM YIELD BAHAMAS, an affiliate of the global investment firm Global Emerging Markets (GEM).
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Australia announces new National Hepatitis B and Hepatitis C Strategies 2026 to 2030
Australia is a step closer to eliminating hepatitis B and C as public health challenges by 2030 with the release of two new national strategies.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
GHIT Fund strengthens partnership with Thailand Science Research and Innovation
Japan-based Global Health Innovative Technology (GHIT) Fund and Thailand Science Research and Innovation (TSRI) have signed a memorandum of understanding (MoU) to strengthen their partnership through co-funding opportunities for research and development (R&D) targeting malaria, tuberculosis, neglected tropical diseases (NTDs), and other infectious diseases with pandemic potential.
1 min |
BioSpectrum Asia May 2026
BioSpectrum Asia
Alphamab Oncology appoints Fei Wang as Chief Financial Officer
Hong Kong-based Alphamab Oncology has announced the appointment of Fei Wang as the Chief Financial Officer (CFO).
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
CarbGeM inks MoU with DSS Imagetech to expand AI business in Indian market
DSS Imagetech, a leading player in medical and research imaging equipment, has announced the signing of a Memorandum of Understanding (MoU) with Japan-based CarbGeM Inc., a developer of artificial intelligence (AI)-powered life science solutions to expand its AI business in the Indian market.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
PHCbi introduces LiCellGrow Cell Expansion System
PHC Corporation's Biomedical Division, a global provider of laboratory sample storage and cell cultivation solutions and subsidiary of Japan's PHC Holdings Corporation, has announced the launch of its new cell expansion system LiCellGrow for research use in Japan and other select countries worldwide.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
CitiusTech appoints Dhaval Shah as Chief Business Officer - MedTech & Life Sciences
CitiusTech, a leading provider of healthcare technology services driving digital and AI excellence in India, has appointed Dhaval Shah to Chief Business Officer - MedTech & Life Sciences.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Thermo Fisher expands immunodiagnostics operations with new distribution centre in Uppsala
Thermo Fisher Scientific Inc. has announced the opening of a new 8,000-square-meter distribution & labeling centre supporting its immunodiagnostics business in Uppsala.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Harbour BioMed appoints Dr Jenny Xie as Head of Global External Innovation
Harbour BioMed, a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, has announced the appointment of Dr Jenny Xie as Chief Scientific Officer, Immunology and Head of Global External Innovation.
1 min |
BioSpectrum Asia April 2027
BioSpectrum Asia
Argo Biopharma ropes in Dr Gena Wang as CFO and CSO
China-based Argo Biopharmaceutical Co., a clinical-stage biotechnology company committed to developing next-generation siRNA therapies, has announced the appointment of Dr Gena Wang as Chief Financial Officer (CFO) and Chief Strategy Officer (CSO), effective March 1, 2026.
1 min |